BMS’ liso-cel uptake prospects for r/r NHL buoyed by payer gains, FDA approval expected

Liso-cel is expected to attain peak sales of $1.3bn in 2026, according to GlobalData consensus. Credit: Shutterstock.



  • Liso-cel